News
- All
- Animation
- Event
- Funding
- Publication
- Thesis
Anti-influenza therapeutic solutions, whether preventive or curative, are sub-optimal. Antivirals currently on the market have a very short efficacy window,…
Today, January 28, the Nebuflag study is being launched at the CHRU in Tours, France. This is the 3rd stage…
Announcement symposium “Epithelial cells: the conductors of inflammation” 📅 Date: March 15, 2025; https://gremi.asso.fr/PGE2uk/uk_registration.htm Preliminary Program Printable Poster (A4, pdf)…
After many years of dedication, Anita will now enjoy a well-deserved retirement. We wish her all the best for this…
Congratulations to Camille David for the successful defense of his thesis, « The influenza virus induces distinct alterations in alveolar…
Congratulations to Thomas, who brilliantly obtained his habilitation to direct research ! This is a remarkable accomplishment that reflects his …
Congratulations to Emilie Barsarc for the successful defense of her thesis, « Study of MAIT cell impact during pneumococcal-mediated pneumonia« . …
Join the ERS Virtual School of Nebulisation of Drugs for Treatment of Respiratory Infections and Disease in collaboration with the…